Here are nine cancer studies and research you might have missed:
The Latest
Oncology leaders face many challenges in the field, and three in particular are top of mind: timeliness, treatment options and innovations.
Many agencies are delaying cancer trials and research due to cancer drug shortages, which may have a long-term effect on treatments, CNN reported July 20.
Richard Creech, MD, a pioneering medical oncologist, researcher and longtime leader, died July 1 of cancer at 83, The Philadelphia Inquirer reported July 19.
Nashville-based Tennessee Oncology announced plans to build a $120 million medical center in downtown Nashville, according to a July 19 report in The Tennessean.
A breast cancer vaccine has shown promise in a phase 1 trial spearheaded by researchers at University of Washington's Cancer Vaccine Institute and is preparing to move to phase 2, a July 17 Fred Hutchinson Cancer Center news release said.
Houston-based University of Texas MD Anderson Cancer Center has received a gift of $16.25 million for brain cancer and neuroscience research, according to a July 18 news release shared with Becker's.
Clinicians are using robot-assisted technology to diagnose and treat lung cancer in a same-day procedure at Baptist Health Paducah (Ky.) and four other system hospitals.
Michael Postow, MD, chief of melanoma service at Memorial Sloan Kettering Cancer Center in New York City, picked oncology because it was a place where he could make the biggest impact.
Detroit-based Barbara Ann Karmanos Cancer Institute named Arnold D'Ambrosio chief development officer, effective July 10.